Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 64, No. 2, 2011
Issue release date: June 2011
Section title: Original Paper
Editor's Choice -- Free Access
Neuropsychobiology 2011;64:93–101

Brain Activity Supporting Working Memory Accuracy in Patients with Paranoid Schizophrenia: A Functional Magnetic Resonance Imaging Study

Wolf C.a · Linden S.a, b · Jackson M.C.a · Healy D.b · Baird A.c · Linden D.E.J.a, b · Thome J.c, d
aWolfson Centre for Cognitive and Clinical Neuroscience, School of Psychology, Bangor University, Bangor, and bDepartment of Psychological Medicine and Neurology, Cardiff University, Cardiff, and cLaboratory of Molecular Psychiatry and Pharmacology, Institute of Life Science, School of Medicine, Swansea University, Swansea, UK; dDepartment of Psychiatry and Psychotherapy, Rostock University, Rostock, Germany
email Corresponding Author

Prof. David Linden

MRC Centre for Neuropsychiatric Genetics and Genomics

Sir Henry Wellcome Building, Cardiff University School of Medicine

Cardiff CF14 4XN (UK)

Tel. +44 2920 687 928, E-Mail linden@cardiff.ac.uk

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


Background: Dysfunctional working memory (WM) has been recognized as one of the most consistent deficits in schizophrenia. Studies that investigated the neural correlates of WM-related pathology by comparing patients with schizophrenia and control participants have produced controversial results, reporting task-related hyper- or hypoactivity in frontoparietal networks. Method: We addressed this question by comparing BOLD signals for accurate responses during a WM task for emotional faces between a homogeneous group of high-performing patients and a control group. Results: Our results confirm previous findings of left prefrontal hyperactivity contrasted with hypoactivity in right prefrontal cortex to support WM performance. We also extend previous work by reporting enhanced activity in higher visual areas of patients during encoding and maintenance. Conclusion: Our findings and those of the literature can be integrated into a model, where preserved visual cognition in high-functioning patients with hypofrontality is explained by activation of contralateral homologue areas combined with enhanced recruitment of sensory areas.

© 2011 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: January 25, 2010
Accepted: December 20, 2010
Published online: June 21, 2011
Issue release date: June 2011

Number of Print Pages: 9
Number of Figures: 5
Number of Tables: 0

ISSN: 0302-282X (Print)
eISSN: 1423-0224 (Online)

For additional information: http://www.karger.com/NPS

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.